WSO - February 2024 - 142

142
International Journal of Stroke 19(2)
Acknowledgements
We would like to acknowledge Dr Kathryn Hayward and Dr Gert
Kwakkel for co-chairing and convening the third Stroke Recovery
and Rehabilitation Roundtable (SRRRIII), Dr Emily Dalton for
supporting SRRRIII conduct and organization of the in-person
meeting. We thank our Advisory Group members: Lived
Experience (Brenda Booth, Shailaja Buvaneswari, Jim Koehler,
Rachel Peak, Jessica Peters, Ben Schelfhaut), Mechanisms (Brad
Aouizerat, Andrew Bivard), Communication/Aphasia (Jacqueline
Laures-Gore, Jessica Riccardi, Eve Mercer), Melanie Fleming,
and members of the other SRRRIII who provided feedback.
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with
respect to the research, authorship, and/or publication of this
article.
Funding
The author(s) disclosed receipt of the following financial support
for the research, authorship, and/or publication of this article:
Canadian Partnership for Stroke Recovery, NHMRC Centre of
Research Excellence to Accelerate Stroke Trial Innovation and
Translation (GNT2015705), and unrestricted educational grants
provided by Ipsen Pharma and Moleac.
Statement of endorsement
The World Stroke Organization (WSO) endorses the goals of the
Stroke Recovery and Rehabilitation Roundtable research activity,
which are consistent with the mission of the WSO.
ORCID iDs
Coralie English
Dawn B Simpson
Sandra A Billinger
Annapoorna Kuppuswamy
0814
Mansur A Kutlubaev
Anners Lerdal
Ellyn A Riley
Gillian Mead
Brad A Sutherland
Connie HY Wong
https://orcid.org/0000-0001-5910-7927
https://orcid.org/0000-0002-9386-4830
https://orcid.org/0000-0002-1618-7207
https://orcid.org/0000-0002-4288https://orcid.org/0000-0003-1001-2024
https://orcid.org/0000-0002-7144-5096
https://orcid.org/0000-0003-0652-3104
https://orcid.org/0000-0002-0791-0950
https://orcid.org/0000-0002-9020-1847
https://orcid.org/0000-0001-7494-2023
Supplemental
material
Supplemental material for this article is available online.
References
1. Zhan J, Zhang P, Wen H, et al. Global prevalence estimates
of poststroke fatigue: a systematic review and meta-analysis.
Int J Stroke. 2023; 18: 1040-1050.
2. Mead GE, Sposato LA, Sampaio Silva G, et al. A systematic
review and synthesis of global stroke guidelines on behalf of
International Journal of Stroke, 19(2)
the World Stroke Organization. Int J Stroke 2023; 18: 499-
531.
3. Hill G, Regan S and Francis R. Research priorities to improve
stroke outcomes. Lancet Neurol 2022; 21: 312-313.
4. Duncan F, Kutlubaev MA, Dennis MS, Greig C and Mead
GE. Fatigue after stroke: a systematic review of associations
with impaired physical fitness. Int J Stroke 2012; 7: 157-162.
5. Riley EA, Hart E, Preston JL, Wu Y and Ashaie S.
Pervasiveness of speech-language disorders and fatigue in
stroke: a systematic scoping review. J Commun Disord 2021;
93: 106145.
6. Zhang S, Cheng S, Zhang Z, Wang C, Wang A and Zhu W.
Related risk factors associated with post-stroke fatigue: a
systematic review and meta-analysis. Neurol Sci 2021; 42:
1463-1471.
7. Douven E, Köhler S, Schievink SHJ, et al. Temporal associations
between fatigue, depression, and apathy after stroke:
results of the cognition and affect after stroke, a prospective
evaluation of risks study. Cerebrovasc Dis 2017; 44:
330-337.
8. Choi-Kwon S, Choi J, Kwon SU, Kang DW and Kim JS.
Fluoxetine is not effective in the treatment of poststroke
fatigue: a double-blind, placebo-controlled study. Cerebrovasc
Dis 2007; 23: 103-108.
9. Skogestad IJ, Kirkevold M, Indredavik B, Gay CL and Lerdal
A. Lack of content overlap and essential dimensions-a
review of measures used for post-stroke fatigue. J Psychosom
Res 2019; 124: 109759.
10. Keeney RL. Value-focused thinking: identifying decision
opportunities and creating alternatives. Eur J Oper Res 1996;
92: 537-549.
11. Ablewhite J, Nouri F, Whisker A, et al. How do stroke survivors
and their caregivers manage post-stroke fatigue? A qualitative
study. Clin Rehabil 2022; 36: 1400-1410.
12. Rothwell K, Boaden R, Bamford D and Tyrrell PJ. Feasibility
of assessing the needs of stroke patients after six months using
the GM-SAT. Clin Rehabil 2013; 27: 264-271.
13. Bivard A, Lillicrap T, Krishnamurthy V, et al. MIDAS
(Modafinil in Debilitating Fatigue After Stroke): a randomized,
double-blind, placebo-controlled, cross-over trial.
Stroke 2017; 48: 1293-1298.
14. Poulsen MB, Damgaard B, Zerahn B, Overgaard K and
Rasmussen RS. Modafinil may alleviate poststroke fatigue: a
randomized, placebo-controlled, double-blinded trial. Stroke
2015; 46: 3470-3477.
15. Johansson B, Carlsson A, Carlsson ML, Karlsson M,
Nilsson MK, Nordquist-Brandt E and Rönnbäck L.
Placebo-controlled cross-over study of the monoaminergic
stabiliser (−)-OSU6162 in mental fatigue following stroke
or traumatic brain injury. Acta Neuropsychiatr 2012; 24:
266-274.
16. Guo YH, Chen HX and Xie RM. Effects of qi-supplementing
dominated Chinese materia medica combined with rehabilitation
training on the quality of life of ischemic post-stroke
fatigue patients of qi deficiency syndrome. Chin J Integ Trad
West Med 2012; 32: 160-163.
17. Gurak S and Parfenov V. Asthenia after stroke and myocardial
infarction and its treatment with Enerion. Clin Gerontol 2005;
8: 9-12.
https://orcid.org/0000-0001-5910-7927 https://orcid.org/0000-0002-9386-4830 https://orcid.org/0000-0002-1618-7207 https://orcid.org/0000-0002-4288 https://orcid.org/0000-0003-1001-2024 https://orcid.org/0000-0002-7144-5096 https://orcid.org/0000-0003-0652-3104 https://orcid.org/0000-0002-0791-0950 https://orcid.org/0000-0002-9020-1847 https://orcid.org/0000-0001-7494-2023
WSO - February 2024

Table of Contents for the Digital Edition of WSO - February 2024
